CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-03 | FRIEDMAN PAUL A Director | Grant or award | +10,273 | $0.73 | $7K | 18,819 |
| 2017-01-06 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-01-06 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2017-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-01-05 | ONeill James E Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2017-01-05 | ONeill James E Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2017-01-05 | ONeill James E Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-01-05 | Eliasof Scott SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2017-01-05 | Eliasof Scott SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-01-05 | Carvajal Alejandra VP, General Counsel | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-01-05 | Carvajal Alejandra VP, General Counsel | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-01-05 | BELOFF GREGG CFO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-01-03 | WALT DAVID R Director | Grant or award | +14,935 | $0.77 | $11K | 193,700 |
| 2017-01-03 | RASTETTER WILLIAM H Director | Grant or award | +24,350 | $0.77 | $19K | 103,039 |
| 2017-01-03 | Parkinson David Ross Director | Grant or award | +16,234 | $0.77 | $13K | 28,488 |
| 2017-01-03 | MCKEE WILLIAM Director | Grant or award | +1,948 | $0.77 | $1K | 3,418 |
| 2017-01-03 | FRIEDMAN PAUL A Director | Grant or award | +4,870 | $0.77 | $4K | 8,546 |
| 2017-01-03 | Arbuckle Stuart A Director | Grant or award | +7,467 | $0.77 | $6K | 13,104 |
| 2016-12-31 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award | +5,733 | $0.60 | $3K | 12,489 |
Page 6 of 18 · 344 trades